Talis Biomedical Corp CEO Brian Blaser receives $5M in 2021
Talis Biomedical Corp reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Talis Biomedical Corp reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, six executives at Talis Biomedical Corp received on average a compensation package of $2M, a 27% decrease compared to previous year.
Average pay of disclosed executives at Talis Biomedical Corp
Brian J. Blaser, Chief Executive Officer, received $5M in total. 56% of Blaser's compensation, or $2.8M, was in stock awards. Blaser also received $2.2M in option awards, $15K in salary, as well as $722 in other compensation.
Robert Kelley, Chief Executive Officer, received a compensation package of $2.2M, which increased by 57% compared to previous year. 82% of the compensation package, or $1.8M, was in option awards.
Kimberly J. Popovits, Chief Executive Officer, earned $1.8M in 2021.
Douglas Liu, Chief Operating Officer, received $1.2M in 2021, which decreases by 15% compared to 2020.
J. Roger Moody, Jr, Chief Financial Officer, earned $970K in 2021.
Brian Coe, Chief Executive Officer, received $622K in 2021, which decreases by 88% compared to 2020.
Related executives
Robert Kelley
Talis Biomedical Corp
Chief Executive Officer
J Moody
Talis Biomedical Corp
Chief Financial Officer
Douglas Liu
Talis Biomedical Corp
Chief Operating Officer
Brian Coe
Talis Biomedical Corp
Chief Executive Officer
Kimberly Popovits
Talis Biomedical Corp
Chief Executive Officer
Brian Blaser
Talis Biomedical Corp
Chief Executive Officer
You may also like
Source: SEC filing on April 26, 2022.